(Q53065630)

English

Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation.

scientific article published on 20 February 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Increased levels of inflammatory and extracellular matrix turnover biomarkers persist despite reverse atrial structural remodeling during the first year after atrial fibrillation ablation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

atrial fibrillation

0 references

1 reference

based on heuristic

inferred from title

author name string

Naoko Sasaki

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Yasuo Okumura

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Ichiro Watanabe

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Hiroaki Mano

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Koichi Nagashima

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Kazumasa Sonoda

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Rikitake Kogawa

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Kimie Ohkubo

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Toshiko Nakai

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Atsushi Hirayama

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

publication date

20 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Journal of Interventional Cardiac Electrophysiology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

39

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

241-249

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Histopathological substrate for chronic atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Inflammation in the genesis and perpetuation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Circulating adiponectin levels in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Induction of cardiac fibrosis by transforming growth factor-beta(1).

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible atrial injury after catheter ablation: evidence from magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation.

1 reference

https://api.crossref.org/works/10.1007%2FS10840-013-9867-6

21 January 2018

Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated plasma levels of transforming growth factor-beta 1 in NIDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of markers of tissue repair after ablation of atrial fibrillation and their relation to left atrial structural changes and clinical ablation outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High plasma concentrations of transforming growth factor-β and tissue inhibitor of metalloproteinase-1: potential non-invasive predictors for electroanatomical remodeling of atrium in patients with non-valvular atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24554250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10840-013-9867-6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24554250

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53065630&oldid=2211970763"